Traditionally, every February, under the auspices of the Public Union "All-Ukrainian Alliance of Ophthalmologists" and with the support of Valartin Pharma LLC, the "All-Ukrainian Ophthalmological Online Marathon" continues its work.
The goal of the project, which has brought together over 2,000 ophthalmologists and specialists from related fields, is education, experience exchange, and professional development. Each seminar includes the analysis of interesting clinical cases and discussions on current issues in the diagnosis and treatment of eye diseases.
The seminar on February 4, 2025, launched this year’s series, focusing on the topic "Retina: Innovations and Challenges Through the Lens of Clinical Cases." As part of its partnership, Oftaxanthin was presented – a comprehensive product containing the most powerful natural antioxidant, the carotenoid astaxanthin, along with vitamins E and C.
Astaxanthin, included in Oftaxanthin, is of great interest to specialists due to its scientifically proven effects, including modulation of oxidative stress (OS) and inflammation, improved retinal blood flow and accommodation, as well as its neuroprotective properties, making it a well-grounded choice for eye disease management.
Oftaxanthin's manufacturer, Valartin Pharma LLC, is a modern Ukrainian pharmaceutical company engaged in the development, production, and promotion of competitive medicinal products and healthcare solutions.
Oftaxanthin is an optimal complex based on astaxanthin and vitamins E and C, designed to support visual function.
Watch the segment of the seminar dedicated to Oftaxanthin at the link.
4 February 2025
You find yourself in a specialized publication, which is part of the site of Valatin Pharma LLC and is intended for medical institutions and doctors (the “certified medical specialists”) and contains professional specialized information about medicines, including prescription medicines, in particular, about their name, characteristics, methods of application, medicinal properties, possible side effects, possible contraindications, and other professional specialized information.
Information about preparations, including prescription medicines of PJSC Pharmaceutical company Darnitsa, is intended solely for familiarizing and is not a guide for self-diagnosis or treatment.
Can you confirm that you have read this restriction on receiving information and you are a medical professional or doctor?